Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives.

Abstract:

:Drug repositioning is a strategy to identify new uses for approved or investigational drugs that are used off-label outside the scope of the original medical indication. In this review we report the most relevant studies about drug repositioning in hematology, reporting the signalling pathways and molecular targets of these drugs, and describing the biological mechanisms which are responsible for anticancer effects. Although the majority of studies on drug repositioning in hematology concern acute myeloid leukemia and multiple myeloma, numerous studies are present in the literature on the possibility to use these drugs also in other hematological diseases, such as acute lymphoblastic leukemia, chronic myeloid leukemia, and lymphomas. Numerous anti-infectious drugs, chemical entities used for the therapy of neurological or endocrine diseases, oral antidiabetics, statins, medications used to treat high blood pressure and heart failure, bisphosphonate, natural substance such as artemisin and curcumin, have found a place in hematological diseases treatment. Moreover, seve.

journal_name

Curr Med Chem

authors

Allegra A,Imbesi C,Bitto A,Ettari R

doi

10.2174/0929867327999200817102154

subject

Has Abstract

pub_date

2020-08-16 00:00:00

eissn

0929-8673

issn

1875-533X

pii

CMC-EPUB-109130

pub_type

杂志文章
  • Development of DNA topoisomerase II-mediated anticancer agents, 3-(9-acridinylamino)-5-hydroxymethylanilines (AHMAs) and related compounds.

    abstract::A series of potential topoisomerase II-mediated anticancer 9-anilinoacridine derivatives, which are designed to avoid bio-oxidation and possessed long duration of drug action, is reviewed. Among these agents, 3-(9-acridinylamino)-5-hydroxymethylaniline (AHMA) derivatives and their alkylcarbamates have been investigate...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867023369231

    authors: Su TL

    更新日期:2002-09-01 00:00:00

  • Nanoparticles: functionalization and multifunctional applications in biomedical sciences.

    abstract::Rapid innovations in nanomedicine have increased the likelihood that engineered nanomaterials will eventually come in contact with humans and the environment. The advent of nanotechnology has created strong interest in many fields such as biomedical sciences and engineering field. Central to any significant advances i...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710794183024

    authors: Subbiah R,Veerapandian M,Yun KS

    更新日期:2010-01-01 00:00:00

  • Targeting IL-17 and IL-23 in Immune Mediated Renal Disease.

    abstract::T helper (Th) cells belong to the adaptive immune system and provide an effective and antigen-specific means of host protection. Th17 cells are a subset of Th cells, characterized by the production of the inflammatory cytokines interleukin (IL)-17A (IL-17A) and IL-17F, which bind to a receptor complex comprised of IL-...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666151030163022

    authors: Ghali JR,Holdsworth SR,Kitching AR

    更新日期:2015-01-01 00:00:00

  • Energy Metabolism Impairment in Migraine.

    abstract::Migraine is a common disabling neurological disorder which is characterised by a recurring headache associated with a variety of sensory and autonomic symptoms. The pathophysiology of migraine remains not entirely understood, although many mechanisms involving the central and peripheral nervous system are now becoming...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180622154411

    authors: Cevoli S,Favoni V,Cortelli P

    更新日期:2019-01-01 00:00:00

  • Rutin as Neuroprotective Agent: From Bench to Bedside.

    abstract::Flavonoids are major dietary constituents of plant-based food found ubiquitously in plant kingdom where they are usually present in substantial amounts. Rutin is a flavonol-type polyphenol which consists of the flavonol quercetin and the disaccharide rutinose. Rutin has been reported to exert diverse biological effect...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666171003114154

    authors: Budzynska B,Faggio C,Kruk-Slomka M,Samec D,Nabavi SF,Sureda A,Devi KP,Nabavi SM

    更新日期:2019-01-01 00:00:00

  • AG490 promotes HIF-1α accumulation by inhibiting its hydroxylation.

    abstract::AG490 is a tyrphostin originally described as a Janus Activated Kinase (JAK) 2 inhibitor. AG490 also inhibits epidermal growth factor receptor (EGFR) and guanylyl cyclases (GC). More recently, AG490 was associated with oxidative stress protection in experimental acute kidney injury models. We now show that AG490 is al...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986712802002554

    authors: Fernández-Sánchez R,Berzal S,Sánchez-Niño MD,Neria F,Gonçalves S,Calabia O,Tejedor A,Calzada MJ,Caramelo C,Deudero JJ,Ortiz A

    更新日期:2012-01-01 00:00:00

  • Small Molecules as Anti-TNF Drugs.

    abstract::Tumor necrosis factor (TNF, TNF-α, cachectin) is a pleiotropic, proinflammatory cytokine with multiple biological effects, many of which are not yet fully understood. Although TNF was initially described as an anti-tumor agent more than three decades ago, current knowledge places it central to immune system homeostasi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150729115553

    authors: Richmond V,Michelini FM,Bueno CA,Alché LE,Ramírez JA

    更新日期:2015-01-01 00:00:00

  • A novel marine drug, SZ-685C, induces apoptosis of MMQ pituitary tumor cells by downregulating miR-200c.

    abstract:OBJECTIVE:We found a novel marine drug, SZ-685C, that was isolated from the secondary metabolites of a mangrove endophytic fungus (No. 1403) collected from the South China Sea, which has been reported to inhibit the proliferation of certain tumor cells. However, its anticancer mechanism remains unknown. The aims of thi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867311320160007

    authors: Chen CH,Xiao WW,Jiang XB,Wang JW,Mao ZG,Lei N,Fan X,Song BB,Liao CX,Wang HJ,She ZG,Zhu YH

    更新日期:2013-01-01 00:00:00

  • Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.

    abstract::APN is an important zinc dependent metallo-exopeptidase; it has been considered as a suitable target for anti-cancer drug design. In this review we focus on the most effective and the most promising inhibitors of aminopeptidase N. Their binding modes to the enzyme, the attempt to explain the origin of the inhibitory a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986708786242840

    authors: Zhang X,Xu W

    更新日期:2008-01-01 00:00:00

  • Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors.

    abstract::The introduction of highly active antiretroviral therapy (HAART) in 1996 dramatically changed the course of HIV infection. This therapy involves the use of at least three agents from two distinct classes of antivirals: a protease inhibitor (PI) in combination with two nucleoside/nucleotide reverse transcriptase inhibi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782360141

    authors: Mastrolorenzo A,Rusconi S,Scozzafava A,Barbaro G,Supuran CT

    更新日期:2007-01-01 00:00:00

  • Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?

    abstract::Reversible phosphorylation is a key mechanism for regulating the biological activity of many human proteins that affect a diverse array of cellular processes, including protein-protein interactions, gene transcription, cell-cycle progression and apoptosis. Once viewed as simple house keeping enzymes, recent studies ha...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867023368836

    authors: Honkanen RE,Golden T

    更新日期:2002-11-01 00:00:00

  • Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin.

    abstract:BACKGROUND:Research on Chromogranin A (CGA) and its derived fragments convincingly demonstrated the multifunctional activity of the 21 amino acid peptide named Catestatin (CST: human CGA352-372, bovine CGA344-364, rat CGA367-387). This review aims to provide a synopsis of the current information concerning the biologic...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170616104759

    authors: Pasqua T,Angelone T,Spena A,Cerra MC

    更新日期:2017-01-01 00:00:00

  • Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors.

    abstract::The Pim (provirus insertion site of Moloney murine leukemia virus) family of serine/threonine protein kinases possesses the fundamental characteristics critical for the biology of eukaryotes, in particular, survival and malignant transformation of cells. The members of this protein family (Pim-1 to Pim-3) are aberrant...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710793348554

    authors: Anizon F,Shtil AA,Danilenko VN,Moreau P

    更新日期:2010-01-01 00:00:00

  • Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development.

    abstract::Adenosine is an important autocoid, exerting its physiological effects on the human body by activation of four different G-protein-coupled-receptors (GPCRs) classified as A(1), A(2A), A(2B), and A(3). These receptors are coupled to secondary messenger systems including adenylate cyclase, inositol phosphate metabolism,...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710792927831

    authors: Romagnoli R,Baraldi PG,Tabrizi MA,Gessi S,Borea PA,Merighi S

    更新日期:2010-01-01 00:00:00

  • Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases.

    abstract::gammadelta T lymphocytes are involved in the defence from viral and mycobacterial infections; however they are also responsible for autoimmune reactions. Herein, we discuss the characteristics of these cells, focusing on the mechanism(s) underlying extravasation and tissue localization. We show that Vdelta1 and Vdelta...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782793835

    authors: Poggi A,Catellani S,Fenoglio D,Borsellino G,Battistini L,Zocchi MR

    更新日期:2007-01-01 00:00:00

  • Targeting DNA Repair Systems in Antitubercular Drug Development.

    abstract::Infections with Mycobacterium tuberculosis, the causative agent of tuberculosis, are difficult to treat using currently available chemotherapeutics. Clinicians agree on the urgent need for novel drugs to treat tuberculosis. In this mini review, we summarize data that prompts the consideration of DNA repair-associated ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180129093546

    authors: Minias A,Brzostek A,Dziadek J

    更新日期:2019-01-01 00:00:00

  • MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.

    abstract::Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes. There are four isoforms p38alpha p38beta, p38gamma, and p38delta. The most thoroughly studied isoform is p38alpha, whose activation has been observed in many hematopoietic and non-h...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986705774462914

    authors: Lee MR,Dominguez C

    更新日期:2005-01-01 00:00:00

  • Rationally designed multitarget anti-HIV agents.

    abstract::Multitarget-directed ligands (MTDLs), an emerging and appealing drug discovery strategy, utilizing a single chemical entity to inhibit multitargets, was confirmed to be effective in reducing the likelihood of drug resistance, diminishing problems of dosing complexity, drug-drug interactions and toxicities, as well as ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867311320130011

    authors: Zhan P,Liu X

    更新日期:2013-01-01 00:00:00

  • Antidiabetic agents from medicinal plants.

    abstract::Currently available therapeutic options for non-insulin-dependent diabetes mellitus, such as dietary modification, oral hypoglycemics, and insulin, have limitations of their own. Many natural products and herbal medicines have been recommended for the treatment of diabetes. The present paper reviews medicinal plants t...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706776360860

    authors: Jung M,Park M,Lee HC,Kang YH,Kang ES,Kim SK

    更新日期:2006-01-01 00:00:00

  • Development and application of Fourier-transform infrared chemical imaging of tumour in human tissue.

    abstract::Fourier-transform infrared (FT-IR) based mapping and imaging is a fast emerging technology which is being increasingly applied to investigate tissues in the high-throughput mode. The high resolution close to the cellular level, the possibility to determine the bio-distribution of molecules of interest (proteins, pepti...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986709787002664

    authors: Petter CH,Heigl N,Rainer M,Bakry R,Pallua J,Bonn GK,Huck CW

    更新日期:2009-01-01 00:00:00

  • Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.

    abstract::The reductive conversion of ribonucleotides to deoxyribonucleotides by ribonucleotide reductase (RR) is a crucial and rate-controlling step in the pathway leading to the biosynthesis of DNA, since deoxyribonucleotides are present in extremely low levels in mammalian cells. Mammalian ribonucleotide reductase (RR) is co...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867013373741

    authors: Li J,Zheng LM,King I,Doyle TW,Chen SH

    更新日期:2001-02-01 00:00:00

  • Analytical techniques for small molecule solid phase synthesis.

    abstract::Although resin-based chemistry offers many practical advantages over conventional solution phase for the synthesis of combinatorial libraries, effective monitoring of reactions conducted on the support remains a challenge. A number of techniques have been developed to enable the analysis of solid phase organic synthes...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867023368737

    authors: Scicinski JJ,Congreveb MS,Kay C,Ley SV

    更新日期:2002-12-01 00:00:00

  • Mitochondria-Targeting Anticancer Metal Complexes.

    abstract:BACKGROUND:Since the serendipitous discovery of the antitumor activity of cisplatin there has been a continuous surge in studies aimed at the development of new cytotoxic metal complexes. While the majority of these complexes have been designed to interact with nuclear DNA, other targets for anticancer metallodrugs att...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180307112029

    authors: Erxleben A

    更新日期:2019-01-01 00:00:00

  • Recent advances in studies on hydroxamates as matrix metalloproteinase inhibitors: a review.

    abstract::Matrix metalloproteinases (MMPs) are a large family of calcium-dependent zinc- containing endopeptidases, which are responsible for the tissue remodeling and degradation of the extracellular matrix (ECM), including collagens, elastins, gelatin, matrix glycoproteins, and proteoglycan. The inappropriate expression of th...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711795471329

    authors: Yadav RK,Gupta SP,Sharma PK,Patil VM

    更新日期:2011-01-01 00:00:00

  • Hyaluronidase inhibitors: a biological and therapeutic perspective.

    abstract::The hyaluronidases (HAases) are a group of less extensively studied glycosidases distributed throughout the animal kingdom and are popularly known as 'spreading factors'. In recent years, HAases received much attention due to their ability to abruptly alter the hyaluronic acid (HA) homeostasis. HAases preferentially d...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986709788453078

    authors: Girish KS,Kemparaju K,Nagaraju S,Vishwanath BS

    更新日期:2009-01-01 00:00:00

  • Honey: An Effective Regenerative Medicine Product in Wound Management.

    abstract::Honey has successfully been used in the treatment of a broad spectrum of injuries including burns and non-healing wounds. It acts as an antibacterial and anti-biofilm agent with anti/pro-inflammatory properties. However, besides these traditional properties, recent evidence suggests that honey is also an immunomodulat...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180510141824

    authors: Martinotti S,Bucekova M,Majtan J,Ranzato E

    更新日期:2019-01-01 00:00:00

  • Antihypertensive therapy in children: differences in medical approach between the United States and Europe.

    abstract::Similarly to a series of chronic diseases, essential arterial hypertension (HTN) may be manifested during childhood as a blood pressure (BP) reading which repeatedly rises above the 95(th) percentile of population-specific standards. Since BP tends to track along the same percentiles throughout life, children with hig...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867321666140304093848

    authors: Bassareo PP,Bassareo V,Iacovidou N,Mercuro G

    更新日期:2014-01-01 00:00:00

  • Stimuli-responsive Carriers for Controlled Intracellular Drug Release.

    abstract:BACKGROUND:Stimuli-responsive carriers are a class of drug delivery systems which can change their physicochemical properties and/or structural conformations in response to specific stimuli. Although passive and active drug targeting has proved to reduce the side effects to normal cells, controlled intracellular drug r...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170830102409

    authors: Sheng Y,Hu J,Shi J,Lee LJ

    更新日期:2019-01-01 00:00:00

  • Managing the liabilities arising from structural alerts: a safe philosophy for medicinal chemists.

    abstract::Bioactivation of xenobiotics can, in certain circumstances, result in the formation of reactive electrophilic species. These reactive metabolites may covalently modify proteins and macromolecules and it has been suggested that protein modification is a key initial step in provoking idiosyncratic adverse drug reactions...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796391714

    authors: Edwards PJ,Sturino C

    更新日期:2011-01-01 00:00:00

  • Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.

    abstract::Fluoxetine is an antidepressant drug, a potent and specific inhibitor of serotonin reuptake (SSRI). Evidence suggests that being compared with tricyclic antidepressants, fluoxetine may cause significantly fewer anticholinergic, antihistaminergic and cardiotoxic side effects in the treatment of major depressive disorde...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: Pacher P,Ungvari Z,Kecskemeti V,Furst S

    更新日期:1998-10-01 00:00:00